Inhibition of emesis by tachykinin NK1 receptor antagonists in Suncus murinus (house musk shrew)

European Journal of Pharmacology

Volumn 366, Issue 2-3, 1999, Pages 243-252

  Rudd, John A ^a   Ngan, Man P ^a   Wai, Man K ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

Emesis; Suncus murinus; Tachykinin NK1 receptor

Indexed keywords

2 [1 IMINO 2 (2 METHOXYPHENYL)ETHYL] 7,7 DIPHENYLPERHYDROISOINDOL 4 ONE; 3 (2 METHOXY 5 TRIFLUOROMETHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; 3 (2 METHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; [2 METHOXY 5 (1 TETRAZOLYL)BENZYL](2 PHENYL 3 PIPERIDINYL)AMINE; COPPER SULFATE; N BENZYL N2 [4 HYDROXY 1 [(1 METHYL 1H INDOL 3 YL)CARBONYL]PROLYL] N METHYL 3 (2 NAPHTHYL)ALANINAMIDE; NICOTINE; PHYSALAEMIN[9 DEXTRO PROLINE SPIRO GAMMA LACTAM 10 LEUCINE 11 TRYPTOPHAN]; TACHYKININ; TACHYKININ RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIEMETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; INTRACEREBRAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VOMITING;

ANIMALS; ANTIEMETICS; COPPER SULFATE; DIPEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; EMETICS; FEMALE; GANGLIONIC STIMULANTS; INDOLES; INFUSIONS, PARENTERAL; MALE; MOTION SICKNESS; NICOTINE; PHYSALAEMIN; PIPERIDINES; RECEPTORS, NEUROKININ-1; SHREWS; STEREOISOMERISM; VOMITING;

EID: 0033002452     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00920-0     Document Type: Article

References (32)

1. Andrews P.L.R., Davis C.J., Bingham S., Davidson H.I.M., Hawthorn J., Maskell L. The abdominal visceral innervation and the emetic reflex: pathways, pharmacology, and plasticity. Can. J. Physiol. Pharmacol. 68:1990;325-345.
2. Andrews P.L.R., Torii Y., Saito H., Matsuki N. The pharmacology of the emetic response to upper gastrointestinal tract stimulation in Suncus murinus. Eur. J. Pharmacol. 307:1996;305-313.
3. 1 receptor antagonist. Br. J. Pharmacol. 116:1995;3149-3157.
4. 1 receptors by use of the non-peptide antagonist, CP 96,345. Br. J. Pharmacol. 104:1992;292-293.
5. 1 receptor antagonist, CP-99,994, in ferrets. Eur. J. Pharmacol. 249:1993;R3-R4.
6. 3H ]substance P binding in rat and guinea-pig shown by the use of peptide agonists and antagonists Eur. J. Pharmacol. 201:1991;231-234.
7. 1 receptor antagonist, FK 888. Br. J. Pharmacol. 107:1992;785-789.
8. Gagnon, J., Roth, J.M., Finzer, W.F., Haycock, K., Feldman, D.S., Simpson, J., 1989. Contrasts. In: Abacus Concepts, SuperANOVA, Abacus Concepts, Berkely, CA, pp. 199-205.
9. 1 receptor antagonists is mediated centrally in the ferret. Br. J. Pharmacol. 112:1994;. 516 pp.
10. 1 receptor antagonist GR203040. Br. J. Pharmacol. 116:1995;3158-3163.
11. 1 receptor antagonist, on motion-induced emesis in Suncus murinus. Br. J. Pharmacol. 116:1995;. 250 pp.
12. 1 receptor, and potent broad-spectrum anti-emetic activity. Regulatory Peptides. 65:1996;45-53.
13. Garret C., Carruette A., Fardin V., Moussaoui S., Peyronel J.-F., Blanchard J.-C., Laduron P.M. Pharmacological properties of a potent and selective nonpeptide substance P antagonist. Proc. Natl. Acad. Sci. 88:1991;10208-10212.
14. Gitter B.D., Waters D.C., Bruns R.F., Mason N.R., Nixon J.A., Howbert J.J. Species differences in affinities of non-peptide antagonists for substance P receptors. Eur. J. Pharmacol. 197:1991;237-238.
15. 1 receptor antagonist, in ferrets. Eur. J. Pharmacol. 305:1996;181-185.
16. 1 receptors in human IM9 and U373 MG cells, using antagonist (FK 888, (±)-CP-96,345, and RP 67580) binding. Eur. J. Pharmacol. 254:1994;221-227.
17. 1 receptor antagonist. Br. J. Pharmacol. 102:1991;. 168 pp.
18. Leslie, R.A., Reynolds, D.J.M., 1992. Functional anatomy of the emetic circuitry in the brainstem. In: Bianchi, A.L., Grélot, L., Miller, A.D., King, G.L. (Eds.), Mechanisms and Control of Emesis, Vol. 223. John Libbey Eurotext, Paris, pp. 19-27.
19. Lucot J.B., Obach R.S., McLean S., Watson J.W. The effect of CP-99994 on the responses to provocative motion in the cat. Br. J. Pharmacol. 120:1997;116-120.
20. 1 receptor. Regulatory Peptides. 46:1993;329-331.
21. 1 receptor. J. Pharmacol. Exp. Ther. 277:1996;900-908.
22. + currents in NG 108-15 cells by substance P and related tachykinins. Br. J. Pharmacol. 119:1996;315-320.
23. 1 receptor antagonists: non-specific effects of racemic RP 67580. Br. J. Pharmacol. 110:1993;1607-1613.
24. 1 receptor antagonists. Eur. J. Pharmacol. 326:1997;201-209.
25. 1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferret. Eur. J. Pharmacol. 250:1993;R5-R6.
26. 1 receptor antagonist CP-99,994. Neuropharmacology. 33:1994;259-260.
27. 1) receptor antagonist CP-99,994. Neuropharmacology. 34:1995;1697-1699.
28. 1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets. Neuropharmacology. 35:1996;1121-1129.
29. Ueno S., Matsuki N., Saito H. Suncus murinus: as a new experimental model for motion sickness. Life Sci. 43:1988;413-420.
30. Wang S.C., Borison H.L. Copper sulfate emesis: a study of afferent pathways from the gastro-intestinal tract. Am. J. Physiol. 154:1951;520-526.
31. 1 receptor. Br. J. Pharmacol. 115:1995;84-94.
32. Won M.H., Matsuo K., Jo S.M., Kang T.-C., Oh Y.S., Choi C.D., Kitoh J. Brainstem origin of the efferent components of the cervical vagus nerve in the house musk shrew Suncus murinus. J. Auton. Nerv. Syst. 71:1998;55-63.